ACT With CF Self-Help Toolkit
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Thomas Jefferson University
- Study ID
- NCT07436351
- Status
- Recruiting
Conditions
- Cystic Fibrosis (CF)
- Depressive and Anxiety Disorders
- Psychological Flexibility
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ACT with CF Self-Help Toolkit — BEHAVIORALThe ACT with CF Self-Help Toolkit will include 6 main modules, each with 3 or 4 kernels, which will be short videos, in which participants will learn new ways to manage uncomfortable experiences and feelings (e.g., anxiety, depression) and to engage in positive behaviors. These videos are based on the main interventions in our ACT with CF individual therapy protocol. For example, the first main module focuses on how the participant wants to live their life (Values Clarification Intervention), and the kernels in this module are 1-3 minute video clips demonstrating different ways to figure this out (Card Sort, 70th Birthday exercise, accessing barriers). This intervention is directly adapted from the ACT with CF manual, which has been studied previously in several forms and studies.
- Waitlist — OTHERParticipants in the waitlist condition will wait for six weeks before receiving the ACT with CF Self-Help Toolkit
Study Details
Acceptance and Commitment Therapy (ACT) tailored to meet the needs of adults living with cystic fibrosis (ACT with CF) is a newer form of talk therapy that has been shown to reduce anxiety \& depression and improve psychological flexibility, and value-based living. The investigators are now trying to find out whether a self-help version of this treatment (ACT with CF - Self Help Toolkit) is also effective in reducing anxiety and depression and improving psychological flexibility and value-based living in adults with CF. Adults with cystic fibrosis are at increased risk for anxiety and depression. This study examines whether a patient-facing therapy, ACT with CF - Self Help Toolkit can help to reduce anxiety and depression among adults with CF. This treatment can be accessed on the participant's smartphone.
Key Dates
- Start date
- Jan 20, 2026
- Status verified
- Feb 2026
- Primary completion
- Apr 30, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Immediate TreatmentThese participants will receive access to the toolkit immediately and use it as instructed for the next six weeks.
- Other: WaitlistThese participants will wait six weeks and be compared to the immediate treatment arm at six weeks before then receiving the treatment over the next six weeks.
Primary Outcome Measure
Anxiety [ Time Frame: at each time point (baseline, 6 weeks, 3 months) ]
Central Contacts
- Virginia O'Hayer, PhD919-943-6738
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 |
Find similar trials in Philadelphia, PA
Related Studies
- Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)Recruiting · Jaeb Center for Health Research · Birmingham, Alabama
- Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung InfectionPHASE1 · Not Yet Recruiting · Ghady Haidar · San Diego, California
- Study to Enable New Diagnostics for Pulmonary Microbes in People With CFNot Yet Recruiting · Chris Goss · La Jolla, California
- Phase 2 Study to Assess the Safety and Efficacy of ANG003PHASE2 · Recruiting · Anagram Therapeutics, Inc. · Long Beach, California